Kliničke studije za Мигрена u državi Džordžija
11 studija za Мигрена traži učesnike na lokacijama u državi Džordžija.
Gradovi u državi Džordžija
Zvanični tekst studije (na engleskom)
Study of EVO756 in Adults With Migraine
- Clinical Integrative Research Center of Atlanta, Atlanta
- Accel Research Site-Decatur-Alcanza, Decatur
Тражи се учесникФаза 2
Узраст од 18 до 64 · Оба пола · Ажурирано 13. 11. 2026. · NCT07616128A Study to Assess the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
- Clinical Integrative Research Center of Atlanta, Atlanta
- Evergreen Clinical Trials, Norcross
- Velocity Clinical Research, Savannah, Savannah
Тражи се учесникФаза 3
Узраст од 18 до 75 · Оба пола · Ажурирано 12. 11. 2026. · NCT07816367A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
- DelRicht Research, Atlanta
- Drug Studies America, Marietta
- Sleep Care Research Institute d/b/a Clinical Research Atlanta-Stockbridge, Stockbridge
Тражи се учесникФаза 3
Узраст од 18 до 75 · Оба пола · Ажурирано 2. 11. 2026. · NCT07645924Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine
- CenExel iResearch, LLC, Decatur
Тражи се учесникФаза 3
Узраст од 6 до 17 · Оба пола · Ажурирано 27. 10. 2026. · NCT04743141Randomized Study in Children and Adolescents With Migraine: Acute Treatment
- CenExel iResearch, LLC, Decatur
Тражи се учесникФаза 3
Узраст од 6 до 17 · Оба пола · Ажурирано 27. 10. 2026. · NCT04649242Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects
- Clinical Trial Office, Augusta
- Augusta University, Augusta
Тражи се учесникФаза 3
Узраст од 6 до 17 · Оба пола · Ажурирано 14. 10. 2026. · NCT05156398Study Evaluating the Efficacy, Safety, and Tolerability of ASY202 (Dihydroergotamine Mesylate [DHE] Inhalation Powder Delivered Via a Multidose Dry Powder Inhaler) for the Acute Treatment of Migraine in Adult Patients
- Conquest Research, Atlanta
Тражи се учесникФаза 2
Узраст од 18 до 65 · Оба пола · Ажурирано 9. 10. 2026. · NCT07646613A Study to Learn About the Study Medicine Called Zavegepant (PF-07930207) in Children With a History of Migraine
- Coastal Heritage Clinical Research, Hinesville
Тражи се учесникФаза 1
Узраст од 6 до 11 · Оба пола · Ажурирано 28. 9. 2026. · NCT06995729Responding With Evidence and Access for Childhood Headaches
- Clinical Integrative Research Center of Atlanta, Inc, Atlanta
Тражи се учесник
Узраст од 10 до 17 · Оба пола · Ажурирано 21. 9. 2026. · NCT05889624Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
- Rare Disease Research /ID# 231046, Atlanta
- Clinical Integrative Research Center of Atlanta (CIRCA) /ID# 231134, Atlanta
- Coastal Georgia Child Neurology /ID# 231409, Brunswick
- и још 1
Тражи се учесникФаза 3
Узраст од 6 до 17 · Оба пола · Ажурирано 14. 9. 2026. · NCT05125302A Pivotal Clinical Study to Evaluate the MySalvia System for the Treatment of Resistant Migraine
- Vista Clinical Research, Newnan
Тражи се учесник
Узраст од 22 до 84 · Оба пола · Ажурирано 28. 8. 2026. · NCT07719608Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.